PCR assessment of Chlamydia trachomatis infection of semen specimens processed for artificial insemination

Y Pannekoek1, S M Westenberg, J de Vries

  • 1Department of Medical Microbiology, Department of Obstetrics and Gynecology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. y.pannekoek@amc.uva.nl

Insights

A new PCR test can detect Chlamydia trachomatis in donor semen, revealing a 4% infection rate in asymptomatic donors. This finding highlights the need for direct semen testing to improve the microbiological quality of artificial insemination by donor (AID) procedures.

Area of Science:

  • Reproductive Medicine
  • Microbiology
  • Infectious Diseases

Background:

  • Donor semen quality is crucial for artificial insemination by donor (AID) success.
  • Chlamydia trachomatis is a common sexually transmitted infection that can be asymptomatic.
  • Current screening methods may not adequately detect Chlamydia trachomatis in donor semen.

Purpose of the Study:

  • To develop and validate a PCR assay for detecting Chlamydia trachomatis in cryopreserved donor semen.
  • To determine the prevalence of Chlamydia trachomatis infection in asymptomatic semen donors.
  • To assess the risk of cross-contamination and the duration of shedding in infected donors.

Main Methods:

  • Development of a Chlamydia trachomatis-specific PCR assay targeting the plasmid.
  • Testing of 669 cryopreserved ejaculates from 97 asymptomatic donors.
  • Sequence analysis of omp1 genes for strain typing and cross-contamination assessment.

Main Results:

  • The PCR assay had a lower limit of detection of 2.5–5 elementary bodies/µL.
  • A prevalence of 4% (12/669 ejaculates) for Chlamydia trachomatis infection was found among donors.
  • Infected donors shed C. trachomatis in semen for extended periods (up to 16 months), with evidence of cross-contamination.

Conclusions:

  • Chlamydia trachomatis is present in cryopreserved donor semen, posing a risk to AID programs.
  • Direct PCR testing of semen is recommended for donors not recently screened.
  • Implementing direct semen testing will enhance the microbiological safety of AID.